Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Identification and management of unusual pathogens in cystic fibrosis.

× No keyword cloud information.

30 in total

Review 1. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors: David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal: Am J Respir Crit Care Med Date: 2007-02-15 Impact factor: 21.405

2. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.

Authors: Frans De Baets; Petra Schelstraete; Sabine Van Daele; Filomeen Haerynck; Mario Vaneechoutte
Journal: J Cyst Fibros Date: 2006-06-21 Impact factor: 5.482

3. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium.

Authors: D A Henry; M E Campbell; J J LiPuma; D P Speert
Journal: J Clin Microbiol Date: 1997-03 Impact factor: 5.948

4. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis.

Authors: J R Govan; P H Brown; J Maddison; C J Doherty; J W Nelson; M Dodd; A P Greening; A K Webb
Journal: Lancet Date: 1993-07-03 Impact factor: 79.321

5. Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial.

Authors: Shawn D Aaron; Katherine L Vandemheen; Wendy Ferris; Dean Fergusson; Elizabeth Tullis; David Haase; Yves Berthiaume; Neil Brown; Pearce Wilcox; Veronica Yozghatlian; Peter Bye; Scott Bell; Francis Chan; Barbara Rose; Alphonse Jeanneret; Anne Stephenson; Mary Noseworthy; Andreas Freitag; Nigel Paterson; Steve Doucette; Colin Harbour; Michel Ruel; Noni MacDonald
Journal: Lancet Date: 2005 Aug 6-12 Impact factor: 79.321

6. In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial combinations.

Authors: T S Krueger; E A Clark; D E Nix
Journal: Diagn Microbiol Infect Dis Date: 2001 Sep-Oct Impact factor: 2.803

7. Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis.

Authors: G B Rogers; M P Carroll; D J Serisier; P M Hockey; G Jones; V Kehagia; G J Connett; K D Bruce
Journal: J Clin Microbiol Date: 2006-07 Impact factor: 5.948

Review 8. Molecular epidemiology of Burkholderia species.

Authors: Tom Coenye; John J LiPuma
Journal: Front Biosci Date: 2003-01-01

9. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia.

Authors: S D Aaron; W Ferris; D A Henry; D P Speert; N E Macdonald
Journal: Am J Respir Crit Care Med Date: 2000-04 Impact factor: 21.405

10. Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis.

Authors: C H Goss; N Mayer-Hamblett; M L Aitken; G D Rubenfeld; B W Ramsey
Journal: Thorax Date: 2004-11 Impact factor: 9.139

2 in total

1. Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis.

Authors: Christopher R Sudfeld; Elliott C Dasenbrook; William G Merz; Karen C Carroll; Michael P Boyle
Journal: J Cyst Fibros Date: 2009-12-31 Impact factor: 5.482

2. Combination antimicrobial susceptibility testing of multidrug-resistant Stenotrophomonas maltophilia from cystic fibrosis patients.

Authors: K E N Milne; I M Gould
Journal: Antimicrob Agents Chemother Date: 2012-05-14 Impact factor: 5.191

2 in total